Author | Type of study | Country | Study population | Overall number of patients | Analytical method used | Factors included in multivariable model | Disease, disease severity, or death | Definition of severity |
---|---|---|---|---|---|---|---|---|
Cai [19] | Retrospective cohort | China | Hospitalised patients, single hospital | 298 | Univariable; logistic regression | N/A; age, sex, comorbidities, clinical markers, travel history | Disease severity | As per the international guidelines for community-acquired pneumonia, with a scoring system based on demographics, comorbid illness, physical examination findings, and laboratory and radiographic findings |
Chen [20] | Retrospective cohort | China | Hospitalised patients, single hospital | 249 | Logistic regression | Age, sex, comorbidities and a range of clinical measures | Disease severity | ICU admission |
Chen [21] | Retrospective cohort with a nested case-control study | China | Hospitalised patients (moderately, severely or critically ill), single hospital | 274 | Univariable | N/A | Death | N/A |
Chen [22] | Case-control | China | COVID-19 vs. pneumonia negative for SARS-CoV-2 | 104 (78 COVID-19) | Univariable | N/A | Disease | N/A |
Chen [23] | Retrospective cohort | China | Hospitalised patients, single hospital | 21 | Univariable | N/A | Disease severity | Severe meets any of the following criteria- respiratory distress, RR ≥ 30 breaths/min; SpO2 ≤ 93% at rest; and PaO2/FIO2 ≤ 300. Patients with greater than 50% lesion progression within 24 to 48 h in pulmonary imaging. |
Cheng [24] | Case-control | China | Patients presenting with fever diagnosed with pneumonia by specialists with chest CT scans | 38 (11 COVID-19) | Univariable | N/A | Disease | N/A |
Chinese CDC [25] | Retrospective cohort | China | Nationwide surveillance | 72,314 | Univariable | N/A | Death | N/A |
Fan [26] | Retrospective cohort | Singapore | Hospitalised patients, National Centre for Infectious Diseases | 67 | Univariable | N/A | Disease severity | ICU admission |
Grasselli [27] | Prospective cohort with a nested case-control study | Italy | Hospitalised in ICU across 72 hospitals | 1591 | Univariable | N/A | Death | N/A |
Han [28] | Retrospective cohort | China | Hospitalised patients, single hospital | 273 | Univariable | N/A | Disease severity | Severe met at least one of the following conditions: a) shortness of breath, RR ≥ 30 times/min, b) oxygen saturation (resting state) ≤93%, or c) PaO2/FiO2 ≤ 300 mmHg., in addition to positive SARS-CoV-2 RNA nucleic acid test by Reverse transcription polymerase chain reaction, fever, or other respiratory symptoms (the typical CT image abnormities of viral pneumonia were optional). Critical patients also needed to meet at least one of the extra following conditions: a) respiratory failure that needs to receive mechanical ventilation; b) shock; and c) multiple organ failure that need to be transferred to the ICU. |
Huang [29] | Retrospective cohort | China | Hospitalised patients, single hospital | 41 | Univariable | N/A | Disease severity | ICU admission |
ICNARC [30] | Case-control (disease) / Prospective cohort (disease severity) | England, Northern Ireland and Wales | Hospitalised patients in ICU across a network of hospitals | 12,502 (6720 COVID-19) | Univariable | N/A | Disease; Disease severity | Receiving advanced, as opposed to basic, respiratory support |
Liang [31] | Prospective cohort | China | Hospitalised patients across 575 hospitals | 1590 | Logistic regression; Cox regression | Logistic model adjusted for age, sex, smoking history, comorbidities, cancer | Disease severity, Death | Invasive ventilation, ICU admission, death |
Liu [32] | Retrospective cohort | China | Hospitalised patients, single hospital | 119 | Univariable | N/A | Disease severity | Severe- dyspnoea accompanied by hypoxemia, sometimes acute respiratory distress syndrome, septic shock and multiple organ failure |
Liu [33] | Retrospective cohort | China | Hospitalised patients, single hospital | 4880 | Logistic regression | Age, sex | Disease | N/A |
Qiu [34] | Retrospective cohort | China | Hospitalised paediatric patients, three hospitals | 36 | Univariable | N/A | Disease severity | Moderate disease (mild was baseline)- mild pneumonia; symptoms such as fever, cough, fatigue, headache, and myalgia; no complications and manifestations related to severe conditions |
Ruan [35] | Retrospective cohort with a nested case-control study | China | Hospitalised patients across two hospitals with a definitive outcome | 150 | Univariable | N/A | Death | N/A |
Shi [36] | Retrospective cohort | China | Hospitalised patients across a province | 487 | Univariable; logistic regression | N/A; age, sex, hypertension; full list unknown | Disease severity | Severe pneumonia, characterised by fever, cough, dyspnoea, bilateral pulmonary infiltrates, and acute respiratory injury |
Simmonet [37] | Retrospective cohort | France | Hospitalised patients in ICU, single hospital | 124 | Logistic regression | Age, sex, diabetes, hypertension, BMI | Disease severity | Receiving invasive mechanical ventilation, determined when oxygen therapy (≥ 10 L/min) with target SpO2 (90–94%) was ineffective, and when RR was above 25/min, with signs of acute respiratory failure, despite maximal oxygen therapy |
Tian [38] | Retrospective cohort | China | Hospitalised individuals transferred from the hospitals of Beijing to the designated hospitals for specialist treatment of infectious diseases by Beijing Emergency Medical Service | 262 | Univariable | N/A | Disease severity | Severe- dyspnoea or respiratory failure in addition to fever, respiratory symptoms and radiographic evidence of pneumonia |
Wan [39] | Prospective cohort | China | Hospitalised patients, single hospital | 135 | Univariable | N/A | Disease severity | Severe group- respiratory distress, RR ≥ 30 breaths/minute in a resting state, a mean oxygen saturation of ≤93%, and an PaO2/FiO2 ≤ 300 mmHg |
Wang [40] | Case-control | China | Country-wide data compared to historic SARS/MERS | 11,425 (835 COVID-19) | Univariable | N/A | Disease | N/A |
Wang [41] | Retrospective cohort | China | Hospitalised patients, single hospital | 138 | Univariable | N/A | Disease severity | ICU admission |
Wang [42] | Prospective cohort | China | Hospitalised patients, single hospital | 116 | Univariable | N/A | Disease severity | Severe- fever or suspected respiratory infection, plus one of the following: RR > 30 breaths/min; severe respiratory distress; or SpO2 ≤ 93% on room air |
Wang [43] | Cross-sectional | China | Hospitalised patients, single hospital | 69 | Univariable | N/A | Disease severity | SpO2 < 90% |
Wu [44] | Retrospective cohort | China | Hospitalised patients, single hospital | 201 | Univariable; Cox regression | N/A | Disease severity, Death | ARDS, mechanical ventilation |
Wu [45] | Prospective cohort | China | Country-wide data | 44,672 | Univariable | N/A | Death | N/A |
Yang [46] | Retrospective cohort | China | Hospitalised patients, single hospital, admitted to ICU | 52 | Univariable; Cox regression | N/A | Death | N/A |
Yuan [47] | Retrospective cohort | China | Hospitalised patients, single hospital | 27 | Univariable | N/A | Death | N/A |
Zhang [48] | Retrospective cohort | China | Hospitalised patients, single hospital | 140 | Univariable | N/A | Disease severity | Severe COVID-19 was designated when the patients had one of the following criteria: (a) respiratory distress with respiratory frequency ≥ 30/min; (b) pulse oximeter oxygen saturation ≤ 93% at rest; and (c) oxygenation index (PaO2/FiO2) ≤ 300 mmHg. |
Zhang [49] | Retrospective cohort | China | Hospitalised patients (patients with no severe underlying diseases), single hospital | 95 | Univariable | N/A | Disease severity | Severe- RR ≥ 30 times / min; at rest, oxygen saturation ≤ 93%; PaO2/FiO2 ≤ 300 mmHg |
Zhang [50] | Retrospective cohort | China | Hospitalised patients, single hospital | 120 | Univariable | N/A | Disease severity | Severe- when patients met one of the following criteria: (1) respiratory distress with a breathing rate ≥ 30/min; (2) pulse oximeter oxygen saturation ≤ 93% at rest; (3) oxygenation index (PaO2/FiO2) ≤300 mmHg; (4) respiratory failure requiring mechanical ventilation; (5) shock; and (6) combined with other organ failure requiring ICU monitoring and treatment |
Zhou [51] | Retrospective cohort with a nested case-control study | China | Hospitalised patients across two hospitals with a definitive outcome | 191 | Univariable; logistic regression | N/A; age, coronary heart disease, Sequential Organ Failure Assessment score, lymphocyte count, D-dimer | Death | N/A |